Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Patel

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
BMJ Open|May 19, 2026
Do publicly supported generic pharmacies improve financial risk protection? Findings from a nationally representative cross-sectional survey in IndiaNeha Purohit, Aarti Goyal, Gaurav Jyani, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 3, 2017
Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemiaHarilal Patel, Amit Arvind Joharapurkar, Vrajesh Bhaskarbhai Pandya, et al.
Drug Research|February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent ModelHarilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
Journal of Cardiothoracic and Vascular Anesthesia|June 12, 2019
Venovenous Extracorporeal Membrane Oxygenation for Patients With Return of Spontaneous Circulation After Cardiac Arrest Owing to Acute Respiratory Distress SyndromeAbhishek Bhardwaj, Todd Miano, Bram Geller, et al.
Plos One|April 16, 2015
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?Paresh Dave, Bhavin Vadera, Ajay M V Kumar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 22, 2014
Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR)Rebecca Marcantuono, Jacob Gutsche, Maureen Burke-Julien, et al.
Journal of Cardiothoracic and Vascular Anesthesia|November 21, 2017
Does a Mobile ECLS Program Reduce Mortality for Patients Transported for ECLS Therapy for Severe Acute Respiratory Failure?Jacob T Gutsche, Todd A Miano, William Vernick, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Plos One|December 12, 2022
CHSI costing study-Challenges and solutions for cost data collection in private hospitals in IndiaManinder Pal Singh, Riya Popli, Sehr Brar, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
BMJ Open|May 19, 2026
Do publicly supported generic pharmacies improve financial risk protection? Findings from a nationally representative cross-sectional survey in IndiaNeha Purohit, Aarti Goyal, Gaurav Jyani, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 3, 2017
Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemiaHarilal Patel, Amit Arvind Joharapurkar, Vrajesh Bhaskarbhai Pandya, et al.
Drug Research|February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent ModelHarilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
Journal of Cardiothoracic and Vascular Anesthesia|June 12, 2019
Venovenous Extracorporeal Membrane Oxygenation for Patients With Return of Spontaneous Circulation After Cardiac Arrest Owing to Acute Respiratory Distress SyndromeAbhishek Bhardwaj, Todd Miano, Bram Geller, et al.
Plos One|April 16, 2015
Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?Paresh Dave, Bhavin Vadera, Ajay M V Kumar, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 22, 2014
Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR)Rebecca Marcantuono, Jacob Gutsche, Maureen Burke-Julien, et al.
Journal of Cardiothoracic and Vascular Anesthesia|November 21, 2017
Does a Mobile ECLS Program Reduce Mortality for Patients Transported for ECLS Therapy for Severe Acute Respiratory Failure?Jacob T Gutsche, Todd A Miano, William Vernick, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Plos One|December 12, 2022
CHSI costing study-Challenges and solutions for cost data collection in private hospitals in IndiaManinder Pal Singh, Riya Popli, Sehr Brar, et al.
JAAD International|November 17, 2022
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L Bosma, Wouter Ouwerkerk, Madeline J Heidema, et al.
Pageof 6